Key Central Laboratory Capabilities to Enable Successful Immuno-Oncology Clinical Development
Trends and recommendations in laboratory selection
This presentation provides the laboratory and operational requirements of immuno-oncology trials, and explores trends in I-O drug development and biomarker usage. Q2 Solutions presented at the Immuno-Oncology 360° 2019 conference as part of a plenary session.
Q2 Solutions has a unique role in immuno-oncology drug development, providing clinical laboratory services and utilizing early engagement and continuous communication with partners and clients to drive higher quality results.
Download this presentation to learn more.
Patrice Hugo, PhD, Chief Scientific Officer